Guidance Needed To Explain Scope Of MDR’s Confusing Clinical Investigations Clause
Executive Summary
Article 61(5) of the EU’s Medical Device Regulation gives certain manufacturers an exemption from having to perform clinical investigations by demonstrating equivalence to other companies’ products. But to whom does it apply and who could actually make use of it? Dr. Maria Donawa explains why clarification is urgently needed.
You may also be interested in...
Second MDR Polish Notified Body Designation Means EU Total Reaches 33
New designations of notified bodies under the Medical Device Regulation continue to trickle through slowly. The latest brings the EU’s total to 33, still way short of the previous 80 or so under the Medical Devices Directive.
European Commission Reshuffle Sees New Innovation Focus For Devices
Changes have occurred in the management focus within the European Commission’s directorate responsible for medtech but not within the devices leadership; familiar faces remain.
European Regulatory Roundup, August 2022: Stakeholders Start Taking Radical Decisions
The regulation of clinical evidence and cybersecurity as well as lack of auditor availability were among the topics causing most concern to the medtech industry in September. But obstacles to the smooth implementation of the Medical Device and IVD Regulations persist and some actors are taking matters into their own hands.